28.06.2025

Current Buy Recommendations: Top Stocks for Investors

Top Stocks on Expert Lists

In the past trading week, various experts have recommended several stocks for purchase, which are of interest to private investors and shareholders. Here is an overview of the most important buy recommendations and relevant market strategies:

Uber Technologies (WKN: A2PHHG)

Uber is recommended as a top stock for June 2025. The company is a market leader in ridesharing and delivery services – two growth markets with significant scaling potential. In the first quarter of 2025, Uber achieved an adjusted revenue growth of 17% to $11.5 billion, as well as a free cash flow of $2.3 billion at an enterprise value of $189 billion, which makes the stock appear attractively valued. Risks exist from autonomous driving technologies and consolidation pressure, but as a technology leader, Uber has good chances to emerge as a winner from these developments.

Deutsche Bank

The US bank JPMorgan has maintained a target price of €26.30 on Deutsche Bank and rated it as “Overweight,” recommending entry into this stock.

thyssenkrupp nucera

Deutsche Bank Research continues to rate thyssenkrupp nucera as a “Buy” with a target price of €12.

Other Recommended Stocks

  • Nike (NKE), Pfizer (PFE), Campbell (CPB) are among the ten best companies to invest in right now.
  • In the field of artificial intelligence, particularly Snowflake, Nvidia, Microsoft, and also companies like Powell Industries or Broadcom are considered particularly exciting for June 2025.
  • For investors focusing on dividend stocks, banks such as Valley National Bancorp, Universal, Southside Bancshares, Peoples Bancorp, and Huntington Bancshares are interesting due to their attractive dividend yields between about 5% to over 5.6%.

Conclusion

Currently, several attractive stocks are available for private investors: Technology stocks like Uber or AI companies promise growth potential; established financial stocks like Deutsche Bank or dividend-rich banks can offer stability; additionally, well-known blue chips like Nike or Pfizer are worthwhile for diversification.

These recommendations are based on current analyses from renowned financial experts and should be reviewed within the context of an individual investment strategy.